Exhibit 99.6

 

Consent to be Named as a Director Nominee

 

In connection with the filing by Tarsier Pharma Ltd., of the Registration Statement on Form F-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of by Tarsier Pharma Ltd., in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.

 

Dated: May 18, 2026  
   
  /s/ Richard Eiswirth
  Richard Eiswirth